Restructuring transactions and annual general and special meeting
MYDECINE INNOVATIONS GROUP INC. ANNOUNCES RESTRUCTURING TRANSACTIONS AND ANNUAL GENERAL AND SPECIAL MEETING VANCOUVER, BC – (3 May 2024) Mydecine Innovations Group Inc. (CSE: MYCO) (FSE: 0NFA), (OTC: MYCOF) (AQSE: MYIG) (the “Company” or “Mydecine”) announced that it has entered into certain restructuring transactions in order to improve the financial health of the Company. Josh Bartch, CEO of the Company stated: "We are fully committed to the success of Mydecine and these restructuring efforts are intended to highlight that. Through these various restructuring efforts, the